🔎 Trials Near Me

Akèy › Atrit psoryatik › Pennsylvania › Philadelphia

Etid klinik pou Atrit psoryatik nan Philadelphia, PA

6 etid pou Atrit psoryatik ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

Ap rekriteFaz 3
  • Clinical Research Philadelphia, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06807424

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

Ap rekriteFaz 2
  • Clinical Research Philadelphia, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07321873

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Ap rekriteFaz 2
  • Hospital of the University of Pennsylvania ( Site 5134), Philadelphia
Laj 18 a 80 · Tout sèks · Mizajou Sep 14, 2026 · NCT07486960

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
Jiska laj 21 · Tout sèks · Mizajou Aug 27, 2026 · NCT02418442

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

Ap rekriteFaz 4
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Apr 3, 2026 · NCT06454188

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Ap rekriteFaz 3
  • Hospital at the University of Pennsylvania, Philadelphia
Laj 18 a 80 · Tout sèks · Mizajou Oct 9, 2025 · NCT05669833

Etid Atrit psoryatik nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.